Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Business
  • Technology
  • Non-profit
  • Music
  • Financial
  • Society
Washingtoner

SafeBreak® Vascular Cleared for Pediatrics
Washingtoner/10219541

Trending...
  • Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 196
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle
SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line SafeBreak Vascular installed on a pediatric line Lineus Medical
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical, a medical device company focused on reducing IV complications, announced that the company's flagship product, SafeBreak Vascular, has received clearance from the U.S. Food and Drug Administration (FDA) for use in pediatric patients. SafeBreak Vascular has been shown in adult clinical studies to reduce IV complications with its innovative breakaway technology1.

SafeBreak Vascular is the first breakaway device cleared by the FDA and proven to reduce IV complications in adults by 44%1. It fits between the IV tubing from the IV pump and the patient's IV access point at the arm. When there is a damaging force on the line, SafeBreak separates to protect the patient's IV. This innovative feature helps prevent accidental dislodgement of the catheter, as well as other IV complications caused by damaging forces on the IV line1. This is especially important for pediatric patients who may be more active, less inclined to follow instructions, and less aware of their surroundings.

More on Washingtoner
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
  • Longevity Leaders Project to Feature Hunter Ziesing of Global Health Atlas
  • Spokane: SPD Arrest Male Suspected of Burglarizing Home in the Evacuation Zone
  • Tacoma: Update Third Homicide Arrest – 2100 block of N 30th St
  • Slotozilla Reports Strong Growth in Q2 2026

"We are incredibly proud to receive clearance from the FDA for the use of SafeBreak Vascular with pediatric patients," said Vance Clement, CEO of Lineus Medical. "SafeBreak provides a simple, effective solution for preventing IV complications, which reduces IV restarts and additional needlesticks for patients.  Now, it doesn't matter if the patient is 1 or 100 years old, SafeBreak is cleared for use on all peripheral IVs.  Our goal is to have a SafeBreak on every IV line, everywhere in the world, and this additional clearance lets us help one of the most vulnerable populations that needs it the most, our kids."

ABOUT LINEUS MEDICAL

Lineus Medical is the developer of a unique, patented, break-away technology that is designed to work with all types of medical tubing. Complications with feeding tubes, IV lines, urinary catheters and any other type of medical tubing may be reduced as breakaway devices separate to protect the patient. More information about Lineus Medical can be found on the company website:  www.lineusmed.com or you can follow the company on Twitter or LinkedIn.

1 Dipper Study Data on File

MKG-0194 REV 00

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Tacoma Police Department Launches Tacoma Public Safety Partnership
  • Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety
  • Ritz-Carlton Residences Houston Generates Strong Early New Construction Sales at 2120 Post Oak Blvd
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
  • Stage 2 Burn Ban Order in Effect Across Tacoma
  • San Diego Attorney Anthony Z. Vargas Narrows Practice to Employment Law, Representing Employees Only
  • Spokane: Additional PPE Kits Available Tuesday and Thursday
  • Solid Earth Introduces RealtyID, a Universal Identity Spine for the Real Estate Industry
  • BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
  • Cracking the Immortality Code: A Human / AI Long-Term Collaboration Working to Achieve Immortality
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle
  • On the Boards: Proform Builds Announce New Construction in Gig Harbor
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • Phinge & CEO Robert DeMaio Publicly Declare Cash Settlements or Judgments Alone Cannot & Will Not Remedy the Deep Public Harm of Infringing Its IP
  • Dana Flanagan Expands the Authority Architect, Bringing a Nontraditional Approach to Executive Authority, Strategic Access and Business Growth
  • Phinge's Netverse: Reclaiming the Digital Frontier For Everyone Through CEO Robert DeMaio's Vision of a True App-less, User Data Sovereign World
_catLbl0 _catLbl1

Popular on Washingtoner

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 387
  • Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 196
  • From the Racetrack to the Boardroom: Aston Martin and Aramco Formula One Partnership Accelerates Circle8 Group: (N A S D A Q: CIRC) - 112
  • Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
  • Tacoma: Applications Now Being Accepted for three Positions on the Urban Design Board
  • Spokane: Council Member Zappone Awarded Certificate of Municipal Leadership
  • CRG Awarded NASA SEWP VI Contracts in Categories B and C
  • Final Week for Spokane Falls Boulevard Survey
  • Elevate Your Sneakers With Crep Protect Trek Laces
  • Neighbors' Barbershop Launches New Online Haircut Appointment System for Wedgewood & View Ridge Res

Similar on Washingtoner

  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
  • Independent Colbert Packaging Thrives Amid Industrywide Consolidation
  • Longevity Leaders Project to Feature Hunter Ziesing of Global Health Atlas
  • Why U.S. Enterprises Are Replacing Fragmented eCommerce Stacks with AI Driven Platform Like Diginyze
  • No Sugar Baker Continues National Growth with Seattle Market Expansion Across Washington, Idaho, and Alaska
  • Space Ambitions Expanding as New Testing Builds on NASA Results and Targets MEO, GEO and Next-Generation Orbital Markets: Ascent Solar Technologies
  • FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
  • Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention
  • Solid Earth Introduces RealtyID, a Universal Identity Spine for the Real Estate Industry
  • BlazeHive's AI SEO Agent Outranks Human Writers on 500+ Google Top-3 Results in 5 Months, on Autopilot
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute